Sign Up Today and Learn More About Stramsen Biotech Stock
Invest in or calculate the value of your shares in Stramsen Biotech or other pre-IPO companies through EquityZen's platform.
Stramsen Biotech Stock
Stramsen Biotech is a biopharmaceutical company that uses natural plant based approach to develop medicines.
About Stramsen Biotech Stock
Founded
2020
Headquarters
Houston, TX, US
Industries
Software, Artificial Intelligence, Data and Analytics
Stramsen Biotech Press Mentions
Stay in the know about the latest news on Stramsen Biotech
Stramsen Biotech: $25 Million Funding Commitment Raised From GEM Global Yield
pulse2 • Apr 08, 2025
Stramsen Biotech Raises $25M in Funding
finsmes • Apr 08, 2025
Stramsen Biotech Announced $25 Million Funding
citybiz • Apr 08, 2025
Stramsen Biotech Inc. Announced $25 Million Funding Commitment from GEM Global Yield LLC SCS ("GEM")
prnewswire • Apr 07, 2025
Stramsen Biotech Announces Partnership with Nasdaq Private Market (NPM)
prnewswire • Mar 11, 2025
Join now and verify your accreditation status to gain access to:
- Stramsen Biotech Current Valuation
- Stramsen Biotech Stock Price
- Stramsen Biotech Management
- Available deals in Stramsen Biotech and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Stramsen Biotech Cap Table and Funding History by Share Class and Liquidity Preferences
- Stramsen Biotech Revenue and Financials
- Stramsen Biotech Highlights
- Stramsen Biotech Business Model
- Stramsen Biotech Risk Factors
- Stramsen Biotech Research Report from SACRA Research
Trading Stramsen Biotech Stock
How to invest in Stramsen Biotech stock?
Accredited investors can buy pre-IPO stock in companies like Stramsen Biotech through EquityZen funds. These investments are made available by existing Stramsen Biotech shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Stramsen Biotech stock?
Shareholders can sell their Stramsen Biotech stock through EquityZen's private company marketplace. EquityZen's network includes over 370K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."